Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

45

Revenue 2017

Zytiga

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zytiga was produced by Janssen.

Pre-chemotherapy indication for Xtandi in prostate cancer

Pre-chemotherapy indication for Xtandi in prostate cancer Astellas drug set to compete with J&J’s Zytiga. The US FDA has approved the use of the oncology drug Xtandi prior to chemotherapy in patients with advanced prostate cancer. ... Zytiga has performed well in this indication, racking up US sales of $464m

England's Cancer Drugs Fund: Naughty or NICE?

England's Cancer Drugs Fund: Naughty or NICE? Drug. Company. Requests. Avastin (bevacizumab). Roche. 3, 998. Zytiga (abiraterone). Janssen.

Exelixis axes staff as lead cancer programme fails

Exelixis axes staff as lead cancer programme fails prior treatment with docetaxel as well as Johnson &Johnson's Zytiga (abiraterone) or Astellas/Medivation's Xtandi (enzalutamide). ... already revitalised by the recent introductions of Zytiga, Xtandi and Bayer's radiopharmaceutical Xofigo (radium Ra 223

NICE backs Gilead’s Sovaldi in hepatitis C

NICE backs Gilead’s Sovaldi in hepatitis C But health watchdog denies earlier use of Janssen’s Zytiga. NHS patients in England received mixed news today as the region's health watchdog backed a new drug for use in ... No early use for Zytiga. Janssen had harsher words to say about NICE's final

Olysio leads charge at J&J but competition is on the way

Olysio leads charge at J&J but competition is on the way Zytiga (abiraterone) for prostate cancer surged 42 per cent to $562m in the second quarter, psoriasis drug Stelara (ustekinumab) rose by the same margin to $628m and anticoagulant Xarelto (rivaroxaban) was

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....